日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Clostridium botulinum Botulinum neurotoxin type E, partial CSB-YP311468CLQ
CSB-BP311468CLQ
CSB-MP311468CLQ
CSB-EP311468CLQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Type II secretion system protein K (xcpX), partial CSB-YP311469EZX
CSB-EP311469EZX
CSB-BP311469EZX
CSB-MP311469EZX
CSB-EP311469EZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactococcus lactis subsp. lactis Lactococcin-A transport/processing ATP-binding protein LcnC (lcnC), partial CSB-YP311470LNI1
CSB-EP311470LNI1
CSB-BP311470LNI1
CSB-MP311470LNI1
CSB-EP311470LNI1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helenium virus S 12.6 kDa protein CSB-YP311471HCL
CSB-EP311471HCL
CSB-BP311471HCL
CSB-MP311471HCL
CSB-EP311471HCL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae GTP-binding protein GTR1 (GTR1) CSB-YP311472SVG
CSB-EP311472SVG
CSB-BP311472SVG
CSB-MP311472SVG
CSB-EP311472SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas oleovorans Outer membrane protein AlkL (alkL) CSB-YP311473PUQ
CSB-EP311473PUQ
CSB-BP311473PUQ
CSB-MP311473PUQ
CSB-EP311473PUQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Pheromone P-factor receptor (mam2), partial CSB-YP311474SXV1
CSB-EP311474SXV1
CSB-BP311474SXV1
CSB-MP311474SXV1
CSB-EP311474SXV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus laevis Prothyroliberin type B (trh-b) CSB-YP311475XBE
CSB-EP311475XBE
CSB-BP311475XBE
CSB-MP311475XBE
CSB-EP311475XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Leishmania guyanensis Leishmanolysin (gp63) CSB-YP311476LDP
CSB-EP311476LDP
CSB-BP311476LDP
CSB-MP311476LDP
CSB-EP311476LDP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Suid herpesvirus 1 Major capsid protein, partial CSB-YP311477SRG
CSB-EP311477SRG
CSB-BP311477SRG
CSB-MP311477SRG
CSB-EP311477SRG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rat Histone H2B type 1 CSB-YP311478RA
CSB-EP311478RA
CSB-BP311478RA
CSB-MP311478RA
CSB-EP311478RA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Pre-mRNA-splicing factor 38 (PRP38) CSB-YP311479SVG
CSB-EP311479SVG
CSB-BP311479SVG
CSB-MP311479SVG
CSB-EP311479SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Emericella nidulans Putative sterigmatocystin biosynthesis monooxygenase stcW (stcW), partial CSB-YP311480EKF
CSB-EP311480EKF
CSB-BP311480EKF
CSB-MP311480EKF
CSB-EP311480EKF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Relaxosome protein TraY (traY) CSB-YP311481ENL
CSB-EP311481ENL
CSB-BP311481ENL
CSB-MP311481ENL
CSB-EP311481ENL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Multiple sugar-binding protein (msmE) CSB-YP311482FMR
CSB-EP311482FMR
CSB-BP311482FMR
CSB-MP311482FMR
CSB-EP311482FMR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Multiple sugar-binding transport system permease protein msmG (msmG), partial CSB-YP311483FMR1
CSB-EP311483FMR1
CSB-BP311483FMR1
CSB-MP311483FMR1
CSB-EP311483FMR1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Stage V sporulation protein B (spoVB), partial CSB-YP311484BRJ
CSB-EP311484BRJ
CSB-BP311484BRJ
CSB-MP311484BRJ
CSB-EP311484BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant 60 kDa chaperonin 1 (groL1), partial CSB-YP311485FNU
CSB-EP311485FNU
CSB-BP311485FNU
CSB-MP311485FNU
CSB-EP311485FNU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Mitogen-activated protein kinase SLT2/MPK1 (SLT2) CSB-YP311486SVG
CSB-EP311486SVG
CSB-BP311486SVG
CSB-MP311486SVG
CSB-EP311486SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Enterobacteria phage T4 Uncharacterized 6.1 kDa protein in uvsW-uvsY intergenic region (y11A) CSB-YP311487EDZ
CSB-EP311487EDZ
CSB-BP311487EDZ
CSB-MP311487EDZ
CSB-EP311487EDZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×